Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
10X Genomics | 3,303 | 2023q3 | |||||||||
Abbott Laboratories | 193,498 | 2023q2 | |||||||||
Accolade, Inc. (Pennsylva... | 635 | 2022q3 | |||||||||
Accuray | 247 | 2024q2 | |||||||||
Addus HomeCare | 1,677 | 2023q1 | |||||||||
AirSculpt Technologies | 331 | 2023q3 | |||||||||
Alcon | 39,581 | 2022 | |||||||||
Align Technology | 15,122 | 2023q3 | |||||||||
Amedisys | 3,010 | 2023 | |||||||||
American Well | 253 | 2023q3 | |||||||||
AptarGroup | 9,314 | 2023q3 | |||||||||
Asensus Surgical (TransEn... | 66 | 2023q3 | |||||||||
AtriCure | 1,326 | 2022 | |||||||||
Atrion | 750 | 2023q1 | |||||||||
Avanos Medical | 864 | 2023 | |||||||||
Avantor | 17,633 | 2023q3 | |||||||||
AxoGen | 316 | 2023q3 | |||||||||
Baxter International | 21,298 | 2023 | |||||||||
Becton, Dickinson and Co | 71,142 | 2024q1 | |||||||||
Bellerophon Therapeutics | 1 | 2021 |